The potential impact of a prophylactic herpes simplex vaccine

Richard Rupp, David I. Bernstein

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Background: Herpes simplex virus (HSV) infections have a significant impact on health causing a wide range of diseases. Oral-facial and genital sites are the most common locations of infection and may lead to recurrent painful lesions. HSV infection acquired perinatally may result in severe sequelae or even death despite appropriate therapy. Furthermore, it is becoming increasingly clear that genital HSV infections significantly raise the risk of HIV transmission. Objective: To describe the strategies, impediments, and advancements in the development of vaccines to prevent HSV disease. Methods: A review of the literature was performed, limited to prophylactic HSV vaccines and their potential effect on genital herpes, oral-facial disease, and perinatal herpes. Conclusion: There are several vaccine strategies under development that show promise for the treatment these diseases.

Original languageEnglish (US)
Pages (from-to)41-52
Number of pages12
JournalExpert Opinion on Emerging Drugs
Issue number1
StatePublished - Mar 2008


  • Genital herpes
  • Herpes simplex virus
  • Perinatal herpes
  • Vaccine

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'The potential impact of a prophylactic herpes simplex vaccine'. Together they form a unique fingerprint.

Cite this